About 360mg Mycophenolic Acid Delayed Release Tablets
Experience the ultimate protection with Mycofit-S 360, Mycophenolic Acid Delayed Release Tablets at the lowest price. Unlock uncommon benefits for hospital and clinical use, preventing organ rejection with USP-compliant, 360mg white oval tablets. Each lavishly packaged box contains 6 strips of 10 tablets, clearly labeled with green-white printing for easy identification. Manufactured in India, these advanced prescription tablets ensure robust immunosuppression-just as your physician directs. With a long 36-month life span, rest assured of unmatched reliability in every dose. Store in a cool, dry place for maximum efficacy.
Distinctive Features and Application Method
Mycofit-S 360, 360mg Mycophenolic Acid Delayed Release Tablets, stand out for their exceptional efficacy and USP compliance. The oval, white tablets are designed for oral administration, ensuring controlled release as advised by your physician. Perfect for use in clinical and hospital environments, they function as a potent immunosuppressant to prevent organ rejection. The recommended application method is as per your healthcare provider's directions, ensuring tailored support in transplantation management.
Payment, Packaging, and Delivery Details
We offer flexible payment terms for Mycofit-S 360, catering to hospital and clinical partners. Packaging is meticulously done in robust boxed sets, each containing 6 strips of 10 tablets, further protected by green-white printed labeling. Our standard FOB port in India ensures secure global dispatching and swift delivery. Each order is carefully prepared, with timely delivery and dispatching designed to meet urgent medical requirements, assuring reliability from supplier to end-user.
FAQ's of 360mg Mycophenolic Acid Delayed Release Tablets:
Q: How should Mycofit-S 360 tablets be taken for optimal benefit?
A: Mycofit-S 360 tablets should be administered orally, as directed by your physician. They are designed as delayed release tablets to maximize their immunosuppressive effect and should be taken according to the specified dosage guidelines and schedule provided by your healthcare provider.
Q: What is the main indication for using 360mg Mycophenolic Acid Delayed Release Tablets?
A: The main indication for Mycofit-S 360 is the prevention of organ rejection in transplant patients. It is commonly used in hospital and clinical settings as part of an immunosuppressive regimen.
Q: When should Mycofit-S 360 tablets be stored in a specific way?
A: To maintain efficacy and shelf-life, Mycofit-S 360 tablets should always be stored in a cool, dry place and kept in their original packaging until use. Proper storage helps ensure the tablets remain effective throughout their 36-month life span.
Q: Where does the procurement and dispatching of Mycofit-S 360 occur?
A: Procurement, packaging, and dispatching are managed from India, with products shipped globally via the FOB port. Orders are processed swiftly to meet clinical and hospital requirements.
Q: What is the process for purchasing Mycofit-S 360 and how is it packaged?
A: Hospitals and clinics can unlock special offers and flexible payment terms for bulk orders. Each box contains 6 strips of 10 tablets, with green-white printing for easy identification, carefully packaged to prevent damage during delivery.
Q: What are the benefits of using Mycofit-S 360 as per dosage recommendations?
A: Following prescribed dosage recommendations maximizes the effectiveness of Mycofit-S 360 in suppressing immune response and preventing organ rejection, offering patients a more stable post-transplant outcome.